欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/4861/001
药品名称Cabazitaxel Vivanta
活性成分
    • Cabazitaxel 60.0 mg
剂型Concentrate and solvent for solution for infusion
上市许可持有人Vivanta Generics s.r.o. Trtinová 260/1 Cakovice Prague 9,19600 Czech Republic
参考成员国 - 产品名称Netherlands (NL)
Cabazitaxel Vivanta 60 mg concentraat en oplosmiddel voor oplossing voor infusie
互认成员国 - 产品名称
    • Spain (ES)
    • Sweden (SE)
    • Norway (NO)
      Cabazitaxel Medical Valley
    • Finland (FI)
    • Poland (PL)
      Cabazitaxel Medical Valley
    • Germany (DE)
      Cabazitaxel Vivanta 60 mg Konzentrat und Lösungsmittel zur Herstellung einer Infusionslösung
    • Denmark (DK)
    • Ireland (IE)
许可日期2021/11/05
最近更新日期2023/09/13
药物ATC编码
    • L01CD04 cabazitaxel
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase